By DONALD G. McNEIL Jr.
The manufacturer will provide enough of the drug to supply 200,000 patients annually for more than a decade. Critics said it would not be enough to end the AIDS epidemic and questioned the company’s motives.
Published: May 8, 2019 at 08:00PM
from NYT Health https://nyti.ms/2VRY6qm
via IFTTT
from WordPress http://bit.ly/305HGcZ
via IFTTT
No comments:
Post a Comment